Additionally, consideration of the results from clinical studies to evaluate the clinical relevance of Saps in different types of Candida infections and in diverse patient populations, as well as using computational modeling to predict the impact of Saps on the dynamics of Candida infections and to simulate the effects of potential therapeutic interventions, may open new perspectives in the approach for combating fungal infections. The gene discussed is SKAP2; the disease is fungal infectious disease.